Table 3.
Associations between clinicopathological data and protein expression of FPGS (3A) or TS (3B).
| Table 3A | |||
|---|---|---|---|
| Characteristic | Number of patients (%) | Mean pretreatment FPGS H-score ± SEM, median | P-value |
| Histology | 0.1874 | ||
| Epithelioid | 72 (86%) | 235 ± 5, 235 | |
| Non-epithelioid | 10 (12%) | 222 ± 9, 220 | |
| Sex | 0.6379 | ||
| Female | 14 (17%) | 220 ± 17, 235 | |
| Male | 70 (83%) | 234 ± 4, 230 | |
| Side of pleural involvement | 0.7381 | ||
| Left | 34 (40%) | 228 ± 8, 235 | |
| Right | 50 (60%) | 235 ± 5, 230 | |
| Stage | 0.0318 | ||
| IMIG I | 9 (11%) | 221 ± 10, 230 | |
| IMIG II | 24 (29%) | 247 ± 10, 270 | |
| IMIG III | 28 (33%) | 235 ± 7, 240 | |
| IMIG IV | 23 (27%) | 217 ± 8, 210 | |
| Table 3B | |||
|---|---|---|---|
| Characteristic | Number of patients (%) | Mean pretreatment TS H-score ± SEM, median | P-value |
| Histology | 0.4793 | ||
| Epithelioid | 68 (86%) | 217 ± 6, 210 | |
| Non-epithelioid | 9 (11%) | 196 ± 21, 220 | |
| Sex | 0.0039 | ||
| Female | 14 (18%) | 174 ± 14, 170 | |
| Male | 65 (82%) | 221 ± 6, 220 | |
| Side of pleural involvement | 0.5381 | ||
| Left | 32 (40%) | 208 ± 9, 210 | |
| Right | 47 (60%) | 216 ± 7, 220 | |
| Stage | 0.1913 | ||
| IMIG I | 7 (9%) | 197 ± 14, 210 | |
| IMIG II | 24 (30%) | 206 ± 11, 210 | |
| IMIG III | 26 (33%) | 229 ± 10, 240 | |
| IMIG IV | 22 (28%) | 206 ± 10, 217 | |